Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papilloma Virus (HPV) Vaccine”

436 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 436 results

Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Testing effectiveness (Phase 2)Looking for participantsNCT06157151
What this trial is testing

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerHPV-Related CarcinomaHPV-Related Malignancy+2 more
Precigen, Inc 24
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Early research (Phase 1)Study completedNCT04084951
What this trial is testing

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 30
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Testing effectiveness (Phase 2)Study completedNCT00359619
What this trial is testing

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 383
Not applicableStudy completedNCT01077856
What this trial is testing

GARDASIL™ Vaccine Impact in Population Study (V501-033)

Who this might be right for
Human Papillomavirus Infections
Merck Sharp & Dohme LLC 54,516
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Large-scale testing (Phase 3)Study completedNCT00380367
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 110
Post-approval studies (Phase 4)Study completedNCT01386164
What this trial is testing

Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults

Who this might be right for
HIVHuman Papillomavirus
University of Aarhus 92
Testing effectiveness (Phase 2)Study completedNCT00316693
What this trial is testing

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,046
Not applicableUnknownNCT03604393
What this trial is testing

Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise

Who this might be right for
Human Papilloma Virus
Oregon Health and Science University 22,000
Post-approval studies (Phase 4)Looking for participantsNCT05495906
What this trial is testing

Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Who this might be right for
HPVHuman Papilloma VirusHuman Immunodeficiency Virus
University of British Columbia 275
Not applicableEnded earlyNCT02503111
What this trial is testing

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men

Who this might be right for
Anal DysplasiaHuman PapillomavirusAnal Cancer
University Health Network, Toronto 71
Testing effectiveness (Phase 2)Study completedNCT00091130
What this trial is testing

SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

Who this might be right for
Atypical Squamous Cells of Undetermined SignificanceCervical CancerHigh-grade Squamous Intraepithelial Lesion+1 more
National Cancer Institute (NCI) 139
Not applicableStudy completedNCT00573651
What this trial is testing

Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis

Who this might be right for
Arthritis
University Hospitals Cleveland Medical Center 43
Not applicableStudy completedNCT04072159
What this trial is testing

Community Pharmacists Vaccinate Against Cancer

Who this might be right for
Human Papillomavirus Vaccines
Arizona State University 33
Not applicableStudy completedNCT01731496
What this trial is testing

The Efficacy of Reminders to Complete HPV Series

Who this might be right for
Completion of Three Dose Series of HPVImprovement in Vaccine Intervals Between HPV Doses
University of Rochester 749
Large-scale testing (Phase 3)Study completedNCT01461096
What this trial is testing

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 575
Load More Results